Has Mahmoud Houmsse, MD received payments from drug or device companies?

Yes. Drug and device makers reported $40,492 in general payments to Mahmoud Houmsse, MD across 80 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mahmoud Houmsse, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mahmoud Houmsse, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mahmoud Houmsse, MD

Clinical Cardiac Electrophysiology · Columbus, OHNPI 1780630129

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (54.9%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Abbott at 46.3% of the total. Reporting peaked in 2019 at $17,837 and has fallen 92.1% since, to $1,415 in 2025.

$40,492in general payments, 2019–2025

Across 80 payments — averaging $506.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$19K
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$10K
Boston Scientific$10K
Biosense Webster, Inc.$2K
Acutus Medical, Inc.$102
Volta Medical Inc$88
plus $15 from 1 others

$278,087in research payments, 2019–2025

Across 103 payments — averaging $2699.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$177K
Boston Scientific$32K
Abbott$30K
Biosense Webster, Inc.$29K
Biotronik Inc.$10K

What the payments were for

Consulting fees$2,4506%
Speaking & faculty fees$13,87534%
Travel & lodging$22,24855%
Food & beverage$1,9195%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	25	$18,765
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	19	$9,999
Boston Scientific	23	$9,552
Biosense Webster, Inc.	9	$1,971
Acutus Medical, Inc.	1	$102
Volta Medical Inc	2	$88
Amgen	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LifeVest$9,684
Architect system$9,644
VersaCross Access Solution$6,103
CardioMEMS HF System$5,885
GENERAL - THERAPIES$2,533
Ensite Cardiac Mapping System$1,859
Thermocool SF$1,791
AMPLATZER AMULET$977
Watchman$234
EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$175
Carto 3$147

How this compares

$40,492 in reported general payments places this provider in the 75th percentile of 159 clinical cardiac electrophysiology providers in Ohio.

See all clinical cardiac electrophysiology providers in Ohio →

Medicare billing

Part B allowed, 2024

$269,999

Medicare patients

1,362

Services billed

2,424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	322	$401,682
XareltoRivaroxaban	49	$47,684
Dofetilide	112	$22,736
Mexiletine Hcl	57	$7,810
Propafenone Hcl ErPropafenone Hcl	16	$6,214
Metoprolol Succinate	269	$4,196
Amiodarone Hcl	208	$4,077
SotalolSotalol Hcl	151	$2,504
Flecainide Acetate	44	$2,292
Potassium Chloride	51	$1,902
Diltiazem 24hr Er (Cd)Diltiazem Hcl	61	$1,631
Metoprolol Tartrate	77	$591
Propranolol Hcl	13	$521
Carvedilol	57	$441
Warfarin Sodium	29	$244

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Columbus

Anish AminColumbus$1.1M
John HummelColumbus$275K
Auroa BadinColumbus$188K
Ralph AugostiniColumbus$174K
David NemerColumbus$97K
Eugene FuColumbus$96K
Ankur ShahColumbus$75K
Sampath GundaColumbus$73K
Sreedhar BillakantyColumbus$64K
Salvatore SavonaColumbus$49K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →